Jared Acoba, MD
Full Member, Cancer Biology Program, University of Hawaiʻi Cancer Center
Core Clinical Member, Translational and Clinical Research, University of Hawaiʻi Cancer Center
Academic Appointment(s):
Associate Researcher, Translational and Clinical Research, University of Hawaiʻi Cancer Center
Associate Professor, Department of Internal Medicine, John A. Burns School of Medicine
Director of Research, The Queen's Medical Center Cancer Center
Degree(s):
MD, John A. Burns School of Medicine, University of Hawaiʻi at Mānoa
Research Focus
Dr. Acoba is an Associate Researcher at the University of Hawaiʻi Cancer Center and provides support in both clinical and translational research with a focus on gastrointestinal cancers. His efforts have been in developing (1) clinical trial protocols utilizing novel immunotherapeutic agents for the treatment of gastrointestinal cancers and (2) interventions to reduce racial disparities in cancer treatment. Dr. Acoba also participates in oncology cooperative groups as a member of the NCI Community Oncology Research Program Minority/Underserved Community Site.
Selected Publications
Kwee SA, Wong LL, Sato MM, Acoba JD, Rho YS, Srivastava A, Landsittel DP. (2021). Transarterial Radioembolization for Hepatocellular Carcinoma with Major Vascular Invasion: A Nationwide Propensity Score-Matched Analysis with Target Trial Emulation. J Vasc Interv Radiol; Sep;32(9):1258-1266.e6. doi: 10.1016/j.jvir.2021.07.001. Epub 2021 Jul 7. PMID: 34242775
Yoshikawa GT, Simon N, Nakasone RK, Acoba JD. (2021). Disaggregating Data on Pacific Islander Gastric Cancer Patients Reveals Survival Disparity. J Gastrointest Cancer; Jan 4. doi: 10.1007/s12029-020-00579-6. Online ahead of print. PMID: 33392961.
Rho YS, Pagano I, Wong LL, Kwee SA, Acoba JD. (2021). Factors and Survival Implications associated with biopsy of hepatocellular carcinoma. HPB (Oxford); Jul;23(7):1054-1060. doi: 10.1016/j.hpb.2020.11.001. Epub 2020 Nov 20. PMID: 33229278.
Belyea L, Acoba JD. (2020). Internal Medicine Residents' Perception of Cancer Prognosis. J Cancer Educ; Oct;35(5):983-987. doi: 10.1007/s13187-019-01552-z. PMID: 31161583.
Kwee SA, Tiirikainen M, Sato MM, Acoba JD, Wei R, Jia W, Le Marchand L, Wong LL. (2019). Transcriptomics Associates Molecular Features with 18F-Fluorocholine PET/CT Imaging Phenotype and Its Potential Relationship to Survival in Hepatocellular Carcinoma. Cancer Res; Apr 1;79(7):1696-1704. doi: 10.1158/0008-5472.CAN-18-3837. Epub 2019 Feb 13. PMID: 30760520.
Publication list via PubMed
Active Grants
J. Acoba, MPI; J.L. Berenberg, Contact PI
NCI
5UG1CA189804-07
"Hawaii Minority/Underserved NCORP"
This National Community Oncology Research Program (NCORP) grant supports community based cancer clinical trials across an extensive network of oncology providers in the State of Hawaiʻi.
08/01/2019 – 07/31/2025
J. Acoba, PI
TESARO
“Phase II study of TSR-022 in combination with TSR-042 for the treatment of advanced hepatocellular carcinoma”
This funding supports an investigator-initiated trial of immunotherapy for advanced hepatocellular carcinoma. Dr. Acoba holds the IND for this study.